Kanda N - Search Results

1

Identification of a new class of non-electrophilic TRPA1 agonists by a structure-based virtual screening approach.

Araki M, Kanda N, Iwata H, Sagae Y, Masuda K, Okuno Y. Araki M, et al. Among authors: kanda n. Bioorg Med Chem Lett. 2020 Jun 1;30(11):127142. doi: 10.1016/j.bmcl.2020.127142. Epub 2020 Mar 26. Bioorg Med Chem Lett. 2020. PMID: 32249116

2

Discovery of natural TRPA1 activators through pharmacophore-based virtual screening and a biological assay.

Iwata H, Kanda N, Araki M, Sagae Y, Masuda K, Okuno Y. Iwata H, et al. Among authors: kanda n. Bioorg Med Chem Lett. 2021 Jan 1;31:127639. doi: 10.1016/j.bmcl.2020.127639. Epub 2020 Oct 29. Bioorg Med Chem Lett. 2021. PMID: 33129991

3

A chemically unmodified agonistic DNA with growth factor functionality for in vivo therapeutic application.

Ueki R, Uchida S, Kanda N, Yamada N, Ueki A, Akiyama M, Toh K, Cabral H, Sando S. Ueki R, et al. Among authors: kanda n. Sci Adv. 2020 Apr 1;6(14):eaay2801. doi: 10.1126/sciadv.aay2801. eCollection 2020 Apr. Sci Adv. 2020. PMID: 32270033 Free PMC article.

4

Oligonucleotide-Based Mimetics of Hepatocyte Growth Factor.

Ueki R, Ueki A, Kanda N, Sando S. Ueki R, et al. Among authors: kanda n. Angew Chem Int Ed Engl. 2016 Jan 11;55(2):579-82. doi: 10.1002/anie.201508572. Epub 2015 Nov 23. Angew Chem Int Ed Engl. 2016. PMID: 26592704

5

Indirect impact of the COVID-19 pandemic on the incidence of non-COVID-19 infectious diseases: a region-wide, patient-based database study in Japan.

Kanda N, Hashimoto H, Imai T, Yoshimoto H, Goda K, Mitsutake N, Hatakeyama S. Kanda N, et al. Public Health. 2023 Jan;214:20-24. doi: 10.1016/j.puhe.2022.10.018. Epub 2022 Oct 24. Public Health. 2023. PMID: 36436277 Free PMC article.

6

A predictive factor of oral candidiasis in psoriasis patients treated with bimekizumab: Longer disease duration.

Yoneyama M, Hagino T, Saeki H, Fujimoto E, Kanda N. Yoneyama M, et al. Among authors: kanda n. J Dermatol. 2025 Jan 11. doi: 10.1111/1346-8138.17623. Online ahead of print. J Dermatol. 2025. PMID: 39797588 No abstract available.

7

Real-World Screening Data for Liver Fibrosis in Psoriasis Patients Treated with Biologics.

Ichiyama S, Ito M, Ozaki S, Arai T, Atsukawa M, Iwakiri K, Hagino T, Hoashi T, Kanda N, Saeki H. Ichiyama S, et al. Among authors: kanda n. J Nippon Med Sch. 2024;91(6):534-540. doi: 10.1272/jnms.JNMS.2024_91-613. J Nippon Med Sch. 2024. PMID: 39756942 Free article.

8

Identification of Early and Late Responders to Anti-IL-13 Antibody Tralokinumab in Atopic Dermatitis: A Real-World Japanese Study.

Hagino T, Saeki H, Fujimoto E, Kanda N. Hagino T, et al. Among authors: kanda n. Dermatitis. 2024 Dec 27. doi: 10.1089/derm.2024.0460. Online ahead of print. Dermatitis. 2024. PMID: 39729342

9

Predictive factors for responders to deucravacitinib treatment in patients with psoriasis.

Hagino T, Onda M, Saeki H, Fujimoto E, Kanda N. Hagino T, et al. Among authors: kanda n. J Dermatol. 2024 Dec 26. doi: 10.1111/1346-8138.17601. Online ahead of print. J Dermatol. 2024. PMID: 39723549

10

Risk Factors for Long-Term Nutritional Disorders One Year After COVID-19: A Post Hoc Analysis of COVID-19 Recovery Study II.

Kawabata K, Nakamura K, Kanda N, Hemmi M, Suganuma S, Muto Y, Iba A, Hori M, Hosozawa M, Iso H; COVID-19 Recovery Study II Group. Kawabata K, et al. Among authors: kanda n. Nutrients. 2024 Dec 7;16(23):4234. doi: 10.3390/nu16234234. Nutrients. 2024. PMID: 39683627 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

455 results

Search Page

Filters